Sakine Nazik Bahcecioglu
Overview
Explore the profile of Sakine Nazik Bahcecioglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yilmaz I, Turk M, Nazik Bahcecioglu S, Tutar N, Gulmez I
Turk J Med Sci
. 2020 Feb;
50(2):433-441.
PMID: 32093447
Background/aim: Oral corticosteroid (OCS)-dependent severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps (SEA-CRSwNP) would be a suitable phenotype for mepolizumab treatment. This study evaluated the short-term efficacy of mepolizumab...
12.
Baha A, Kokturk N, Nazik Bahcecioglu S, Yapar D, Aksakal N, Gunduz C, et al.
Clin Respir J
. 2020 Jan;
14(4):397-404.
PMID: 31908143
Objective: We aimed to investigate the effect of inhaled corticosteroids (ICS) in the outcomes of community-acquired pneumonia (CAP), as well as to determine if ICS usage is exist among the...
13.
Turk M, Nazik Bahcecioglu S, Tutar N, Oymak F, Gulmez I, Yilmaz I
Turk Thorac J
. 2018 Oct;
19(4):187-192.
PMID: 30322442
Objectives: Omalizumab is a monoclonal antibody that is used as add-on therapy for treating moderate-to-severe persistant atopic asthma in patients with persistant symptoms and frequent exacerbations, despite step 4 treatment...
14.
Yilmaz I, Nazik Bahcecioglu S, Turk M, Tutar N, Oymak F, Gulmez I
J Asthma
. 2018 Apr;
56(2):111-117.
PMID: 29611776
Objective: Eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis (EA-CRS/NP) is a subphenotype of adult-onset eosinophilic asthma. Blood eosinophil levels are shown to be highly elevated in patients with EA-CRS/NP...
15.
Yilmaz I, Nazik Bahcecioglu S, Turk M
Asia Pac Allergy
. 2018 Feb;
8(1):e2.
PMID: 29423369
Bee venom immunotherapy (b-VIT) can be combined with omalizumab therapy in order to suppress systemic reactions developing due to b-VIT itself. Omalizumab acts as a premedication and gains time for...
16.
Yilmaz I, Turk M, Nazik Bahcecioglu S
J Allergy Clin Immunol Pract
. 2017 Nov;
5(6):1807-1808.
PMID: 29122169
No abstract available.
17.
Turk M, Nazik Bahcecioglu S, Yilmaz I
Asia Pac Allergy
. 2017 Aug;
7(3):179-181.
PMID: 28765824
Skin prick tests (SPTs) are widely used to demonstrate an IgE-mediated hypersensitivity reaction to a specific allergen. However, local allergic conditions cannot be diagnosed with SPTs. Local specific IgE production...
18.
Yilmaz I, Turk M, Nazik Bahcecioglu S
Autoimmun Rev
. 2017 Jul;
16(9):992-993.
PMID: 28711579
No abstract available.
19.
Turk M, Yilmaz I, Nazik Bahcecioglu S
Allergol Int
. 2017 Jun;
67(1):85-89.
PMID: 28566225
Background: Previous data have shown the high efficacy of omalizumab in chronic spontaneous urticaria (CSU). However, factors that may be effective on the response to therapy, relapse rates after drug...